Every branded ingredient we offer is supported by peer-reviewed publications covering bioavailability, mechanism of action or efficacy studies. Below are study summaries to help formulation teams in their evidence search.
Human bioavailability profile of liposomal curcumin shows 8.9× higher absorption versus standard market curcumin. In rheumatoid arthritis patients (n=24, 12 weeks), VAS pain score changed by −74.96% versus −8.33% under placebo, with significant improvement in pain and physical function.
Combined data set from multiple human studies. Liposomal curcumin shows consistent superiority in plasma curcumin AUC and Cmax values when compared to the standard form.
A bioavailability study published in the International Journal of Research in Pharmaceutical Sciences (IJRPS). Comparative analysis showing stabilized beta-carotene provides higher plasma exposure than standard forms.
A clinical study published in the International Journal of Traditional & Complementary Medicine. Significant improvement in bowel movement count, stool consistency and patient satisfaction scores versus placebo — without irritation or side effects.
Mechanism presentation (Ver. 03) explaining the dual-mechanism protective profile of Aegle marmelos extract on gastric mucosa. The accompanying patient case study presents symptomatic improvement data in GERD and acidity management.
Mechanism study explaining the cosmeceutical effect mechanism (collagen, antioxidant, enzyme modulation) of triple-active pomegranate extract, with clinical efficacy data in menopausal populations included in the manuscript currently in publication.
The first clinical publication evaluating the effects of the dual-polyphenolic complex on post-exercise muscle damage markers (CK, LDH), perceived pain (DOMS) and recovery time.
The second clinical publication evaluates the dual-polyphenolic complex's effects on endurance performance, VO₂max and muscle stamina. Positive results in both professional and recreational athletes.
A randomized clinical study evaluating the effects of mangiferin-based extract on cognitive performance (attention, memory, reaction time). Publication phase: completed manuscript.
A randomized, double-blind, placebo-controlled crossover trial of bio-optimised berberine (200 mg/day, 14 days). Reported a significant reduction in fasting glucose versus placebo (−9.08 vs −1.36 mg/dl; p<0.0001), a 13.5% reduction in glucose AUC and increased GLP-1 levels. No supplement-related adverse events.
Published study showing Liposomal Vitamin C achieves 88× higher bioavailability versus market vitamin C. In pediatric populations, upper respiratory tract infection (URTI) symptoms were reported to regress within 3–5 days and not to recur over 90 days, with a reduction in additional antibiotic use.
Master antioxidant glutathione in liposomal form provides 18× higher bioavailability than typical market glutathione, supported by stability data confirmed by TEM and phase-contrast.
Comparative study showing liposomal D₃ vitamin form delivers 5.1× higher bioavailability versus traditional oral D₃.
Bioavailability study showing the liposomal form developed to overcome the low absorption challenges of traditional CoQ10 demonstrates 4.3× higher absorption profile.
Comparative studies showing the liposomal forms of resveratrol and berberine, core ingredients of anti-aging and metabolic formulations, deliver 4.2 and 4 times higher bioavailability respectively.
Comparative bioavailability studies showing 3.5× superiority for adaptogen Ashwagandha based on total withanolides, and 5× bioavailability for melatonin — a key sleep formulation ingredient.
All clinical data we offer comes from evidence chains with randomized, controlled study design, appropriate sample size and a peer-reviewed publication process.
Placebo-controlled, double-blind or open-label designs.
Quantitative absorption data with AUC, Cmax, Tmax.
Validation criteria specific to clinical indication (cytokine, score).
Quality through TEM, phase-contrast and particle analysis.